The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The immune response in drug hypersensitivity is normally explained by the hapten hypothesis. It postulates that drugs with a molecular weight of less than 1000 D are too small to cause an immune response per se. However, if a chemically reactive drug or drug metabolite binds covalently to a protein and thus forms a so-called hapten-carrier complex, this modified protein can induce an immune response. This concept has recently been supplemented by the p-i concept (or pharmacological interaction with immune receptors), which postulates that some drugs that lack hapten characteristics can bind directly and reversibly (noncovalently) to immune receptors and thereby stimulate the cells. For example, a certain drug may bind to a particular T-cell receptor, and this binding suffices to stimulate the T cell to secrete cytokines, to proliferate, and to exert cytotoxicity. The p-i concept has major implications for our understanding of drug interaction with the specific immune system and for drug hypersensitivity reactions. It is based on extensive investigations of T-cell clones reacting with the drug and recently of hybridoma cells transfected with the drug-specific T-cell receptor for antigen (TCR). It is a highly specific interaction dependent on the expression of a TCR into which the drug can bind with sufficient affinity to cause signaling. Small modification of the drug structure may already abrogate reactivity. Stimulation of T cells occurs within minutes as revealed by rapid Ca influx after drug addition to drug-specific T-cell clones or hybridoma cells, thus, before metabolism and processing can occur. As the immune system can only react in an immunologic way, the symptoms arising after drug stimulation of immune receptors imitate an immune response after recognition of a peptide antigen, although it is actually a pharmacological stimulation of some T cells via their TCRs. Clinically, the p-i concept could explain the sometimes rapid appearance of symptoms without previous sensitizations and the sometimes chaotic immune reaction of drug hypersensitivity with participation of different immune mechanisms while normal immune reactions to antigens are highly coordinated. Nevertheless, because the reactions lead to expansion of drug-reactive cells, many features such as skin test reactivity and stronger reactivity upon reexposure are identical to real immune reactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380
Hepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661 · cited 1×
“Metabolism may occur in the liver, where it may not necessarily induce an immune response, but actual tolerance.(15) On the other hand, if a reactive compound escapes the tolerogenic environment of the liver or if the immune response to the compound is developed in lymph nodes outside of the liver (such as probably in…”
BackgroundBowen, D. G., Zen, M., Holz, L., Davis, T., McCaughan, G. W., & Bertolino, P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21593 · Cited by 316
Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.
Schnyder, B., Mauri-Hellweg, D., Zanni, M., Bettens, F., & Pichler, W. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119505 · Cited by 281
Self-citationSulfamethoxazole is metabolized to the hydroxylamine in humans
Cribb, A. E., & Spielberg, S. P. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.57 · Cited by 175
Naisbitt, D. J., Gordon, S. F., Pirmohamed, M., Burkhart, C., Cribb, A. E., Pichler, W. J., & Park, B. K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704074 · Cited by 133 · cited 1×
“Animal experiments aimed to prove or disprove the p-i concept by immunizing animals with the inert drug will necessarily failVas inert drugs do not stimulate an immune response under normal conditions.(44) Actually, the p-i concept cannot be proven by usual immunologic tests but is better accessible to pharmacology of…”
BackgroundSelf-citation
Cited by
EAACI Molecular Allergology User's Guide 2.0
Dramburg, S., Hilger, C., Santos, A. F., de las Vecillas, L., Aalberse, R. C., Acevedo, N., Aglas, L., Altmann, F., Arruda, K. L., Asero, R., et al. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13854 · Cited by 298
Postoperative Hemorrhagic Occlusive Retinal Vasculitis
Witkin, A. J., Shah, A. R., Engstrom, R. E., Kron-Gray, M. M., Baumal, C. R., Johnson, M. W., Witkin, D. I., Leung, J., Albini, T. A., Moshfeghi, A. A., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.03.016 · Cited by 145
Pros and Cons of Clinical Basophil Testing (BAT)
Hoffmann, H. J., Knol, E. F., Ferrer, M., Mayorga, L., Sabato, V., Santos, A. F., Eberlein, B., Nopp, A., & MacGlashan, D. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0633-6 · Cited by 50
Metadata
- Authors
- Pichler, W. J.
- Venue
- World Allergy Organization Journal
- Publisher
- Elsevier BV
- Published
- 2008
- Volume
- 1
- Issue
- 6
- Pages
- 96-102
- ISSN
- 1939-4551 (ISSN-L)
- OpenAlex
- W1990462881
- Cited by
- 91
- References
- 6
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors. https://app.cochat.ai/papers/10.1097/wox.0b013e3181778282
- The paper
- Pichler, W. J. (2008). The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors. World Allergy Organization Journal. https://doi.org/10.1097/wox.0b013e3181778282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.